The store will not work correctly when cookies are disabled.
N-(1-methylcyclopropyl)-7-(pyridin-4-yl)isoquinolin-5-amine
ID: ALA4447885
PubChem CID: 155519372
Max Phase: Preclinical
Molecular Formula: C18H14F3N3
Molecular Weight: 329.33
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: FC(F)(F)C1(Nc2cc(-c3ccncc3)cc3cnccc23)CC1
Standard InChI: InChI=1S/C18H14F3N3/c19-18(20,21)17(4-5-17)24-16-10-13(12-1-6-22-7-2-12)9-14-11-23-8-3-15(14)16/h1-3,6-11,24H,4-5H2
Standard InChI Key: VSQXWEDYWHOMEE-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
10.8959 -6.5332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4593 -8.1642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8817 -8.1642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1862 -6.9437 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8817 -8.9770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3141 -7.3542 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
11.6052 -7.7658 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.0410 -8.1642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7668 -9.3834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0297 -10.2252 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.6064 -6.9447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6074 -9.3834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3025 -8.9744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3063 -5.8174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3180 -6.5353 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.3040 -10.6315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4593 -8.9770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0410 -8.9770 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.0289 -9.3759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6074 -10.2252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7668 -7.7578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4813 -5.8199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1850 -7.7578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1850 -9.3834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19 10 2 0
11 7 1 0
22 14 1 0
2 23 2 0
11 6 1 0
5 3 2 0
8 18 1 0
13 19 1 0
16 10 1 0
21 8 2 0
5 24 1 0
1 11 1 0
4 1 1 0
11 15 1 0
13 12 2 0
20 16 2 0
17 9 1 0
9 18 2 0
14 1 1 0
17 2 1 0
23 3 1 0
12 20 1 0
1 22 1 0
23 4 1 0
2 21 1 0
24 17 2 0
5 12 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 329.33 | Molecular Weight (Monoisotopic): 329.1140 | AlogP: 4.80 | #Rotatable Bonds: 3 |
Polar Surface Area: 37.81 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.67 | CX Basic pKa: 5.51 | CX LogP: 2.99 | CX LogD: 2.99 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.75 | Np Likeness Score: -0.61 |
References
1. (2018) 6-6 Fused Bicyclic Heteroaryl Compounds and their Use as LATS Inhibitors, |